Written by The Neurology Devices Market is witnessing steady growth as healthcare providers seek advanced solutions for neurological diagnosis, treatment, and long-term patient management. The market is expected to increase from USD 12.1 billion in 2026 to USD 23.7 billion by 2035. Increasing neurological disease burden, improved reimbursement coverage, and technological innovation are among the major factors driving demand.
AI and machine learning are becoming important elements of next-generation neurological devices. AI-supported imaging and data analysis can assist healthcare professionals in identifying neurological abnormalities and monitoring disease progression. Remote monitoring and telemedicine are also expanding access to neurological care, while smaller and more biocompatible devices are supporting the development of less invasive treatment approaches.
Hospitals remain the dominant end-user segment, accounting for approximately 52% of the market in 2025. Ambulatory surgical centers are projected to be the fastest-growing end-user category, with a 9.1% CAGR, as selected neurological procedures increasingly shift toward outpatient settings. Neurostimulation devices lead the product landscape, while interventional neurology is gaining momentum due to increasing stroke intervention volumes.
North America maintains its leadership position, while Europe represents another major market supported by clinical research and healthcare infrastructure. Asia-Pacific is emerging as a high-growth region, with India and China contributing significantly to regional expansion. Opportunities in closed-loop neurostimulation, predictive diagnostics, remote monitoring, and non-invasive brain stimulation are expected to influence the market outlook through 2035.
Strengthen your strategy with data-backed research insights:
Smart Medical Devices Market Size
Smart Medical Devices Market Share
Smart Medical Devices Market Trends